Humans who are homozygous for inactivating mutations in LRP5 develop osteoporosis pseudoglioma (OPPG), a syndrome characterized by bone and eye abnormalities (Gong et al., 2001). The gene discussed is LRP5; the disease is osteoporosis-pseudoglioma syndrome.